The dinitrothiophenol SN-2 reduces osteoclastogenesis and estrogen deficiency-induced bone loss by inhibiting TRAF6 auto-ubiquitination
Jian Lu, Huang suo Wang, Jun Wang, Tao Fan, Jianbin Hu, Baotong Xun, Xiaodong Jia, Haoyu Feng, Haishan Guan, Yongwen Qiao, Feng Gao · 2026
Read The dinitrothiophenol SN-2 reduces osteoclastogenesis and estrogen deficiency-induced bone loss by inhibiting TRAF6 auto-ubiquitination by Jian Lu, Huang suo Wang, Jun Wang, Tao Fan, Jianbin Hu, Baotong Xun, Xiaodong Jia, Haoyu Feng, Haishan Guan, Yongwen Qiao, Feng Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13273726.txt.
Description
Jian Lu and co-authors tested a synthetic compound against bone loss in a 2026 study. After menopause, falling estrogen speeds the cells that eat bone, called osteoclasts, and bones thin. A signaling step in which the protein TRAF6 tags itself helps drive that overactivity, making it a drug target.
Their compound, SN-2, blocked osteoclast formation from precursor cells in a dose dependent way and reduced the rings these cells use to dissolve bone. It stopped the TRAF6 self tagging, weakened its grip on a partner kinase, and quieted two downstream pathways. In mice that had their ovaries removed to mimic menopause, SN-2 eased bone loss, improved femur strength measures, and curbed osteoclast formation. The authors propose it for diseases of excess bone resorption.
Catalog record
| CREATOR | Jian Lu, Huang suo Wang, Jun Wang, Tao Fan, Jianbin Hu, Baotong Xun, Xiaodong Jia, Haoyu Feng, Haishan Guan, Yongwen Qiao, Feng Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |